Select the sportsbooks and prediction markets you use to unlock more betting opportunities.
Kalshi traders give an 86% chance that at least 25 people will have received Neuralink implants by the end of 2026, and a 63% chance of at least 30.
Kalshi’s contract counts individual implant recipients worldwide. If you’re curious about the cumulative thresholds and what qualifies as a “Neuralink implant” on Kalshi, stay with us.
Neuralink is a neurotechnology company producing implantable brain-computer interfaces. Elon Musk founded it in 2016, and it is headquartered in Del Valle, Texas, near Tesla’s headquarters.
The company began with major investments in neuroscience and experiments on lab rats, then received FDA approval for human trials in May 2023. Noland Arbaugh became the first person to receive a Neuralink implant on January 28, 2024. In March 2024, neural engineer Kip Ludwig called the results “a good starting point” but not a breakthrough. Later that year, Neuralink announced plans to develop an implant to help people with a damaged visual cortex restore vision to some extent. In August and September 2025, Toronto’s University Health Network implanted two patients with cervical spinal cord injuries, the first Neuralink procedures outside the US.
Neuralink reported three participants by the end of 2024, 12 by September 2025 and 21 on January 28, 2026, its latest official total. Neura Pod, which tracks publicly reported patients, counts at least 27 recipients as of November 2026, but Neuralink has not confirmed that figure. Traders can predict the year-end total on Kalshi, the same platform that had the “Neuralink implanted into a living human?” market among its tech predictions in early 2024.
As the end of 2026 approaches, the Neuralink market is heating up, and more people are trading on this topic. Kalshi offers 6 outcomes, each a cumulative threshold for the number of implant recipients, and shows the chance of every outcome occurring, along with contract prices:
| Threshold | Chance | “Yes” Price | “No” Price |
|---|---|---|---|
| At least 25 | 75% | $0.74 | $0.29 |
| At least 30 | 52% | $0.53 | $0.50 |
| At least 40 | 24% | $0.30 | $0.75 |
| At least 50 | 19% | $0.24 | $0.84 |
| At least 75 | 14% | $0.15 | $0.92 |
| At least 100 | 7% | $0.11 | $0.95 |
Odds as of November 9, 2026. Kalshi prices move in real time.
Every patient with the following implants counts for this contract:
You should pay attention to the following concepts that do not count towards this contract:
In case Neuralink merges or changes its name, this contract will follow the successor entity.
Neuralink’s last official total is 21, and the rules exclude implants that are not confirmed. The lower thresholds depend on whether Neuralink or its trial hospitals confirm the implants trackers have reported since January, and the 86% price on at least 25 suggests traders expect that confirmation. The market is available on Kalshi’s desktop site and its prediction market apps for iOS and Android, whether on the desktop site or prediction market apps (iOS and Android), check our similar articles.

Disclaimer: All of the information on this site is for entertainment purposes only. We do NOT accept bets of any kind. The information we provide is accurate and trustworthy to help you make better decisions. When you click or tap on a link on Dimers that leads to a third-party website that we have a commercial arrangement with (such as an online sportsbook), we may earn referral fees. Dimers does not endorse or encourage illegal or irresponsible gambling in any form. Before placing any wagers with any betting site, you must check the online gambling regulations in your jurisdiction or state, as they do vary. If you or someone you know has a gambling problem, crisis counseling and referral services can be accessed by calling 1-800-MY-RESET or 1-800-GAMBLER.
Copyright © [yyyy] Dimers. All Rights Reserved. Proudly part of Cipher Sports Technology Group, 902A Broadway, Floors 6 & 7, New York, NY 10010, United States of America.